Page last updated: 2024-09-05

erlotinib and 4,5,6,7-tetrabromo-2-azabenzimidazole

erlotinib has been researched along with 4,5,6,7-tetrabromo-2-azabenzimidazole in 2 studies

Compound Research Comparison

Studies (erlotinib)	Trials (erlotinib)	Recent Studies (post-2010) (erlotinib)	Studies (4,5,6,7-tetrabromo-2-azabenzimidazole)	Trials (4,5,6,7-tetrabromo-2-azabenzimidazole)	Recent Studies (post-2010) (4,5,6,7-tetrabromo-2-azabenzimidazole)
221	0	180	115	0	57

Protein Interaction Comparison

Protein	Taxonomy	4,5,6,7-tetrabromo-2-azabenzimidazole (IC50)
Chain A, Cell division protein kinase 2	Homo sapiens (human)	15.6
Casein kinase II subunit alpha'	Homo sapiens (human)	0.7325
Casein kinase II subunit beta	Homo sapiens (human)	0.7325
Casein kinase II subunit alpha	Homo sapiens (human)	0.7354
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)	2.68
Casein kinase II subunit alpha 3	Homo sapiens (human)	0.8667

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M	1
Abuo-Rahma, GEA; Badr, M; Bass, AKA; El-Zoghbi, MS; Mohamed, MFA; Nageeb, EM	1

Reviews

1 review(s) available for erlotinib and 4,5,6,7-tetrabromo-2-azabenzimidazole

Article	Year
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors. European journal of medicinal chemistry, 2021, Jan-01, Volume: 209 Topics: Androgen Antagonists; Animals; Antineoplastic Agents; Benzimidazoles; Cyclic Nucleotide Phosphodiesterases, Type 5; Daunorubicin; Doxorubicin; fms-Like Tyrosine Kinase 3; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Molecular Targeted Therapy; Morpholines; Nicotinamide Phosphoribosyltransferase; Nitric Oxide; Pyrimidines; Quinazolines; Structure-Activity Relationship; Transcription Factors	2021

Article

Year

Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.

European journal of medicinal chemistry, 2021, Jan-01, Volume: 209

Topics: Androgen Antagonists; Animals; Antineoplastic Agents; Benzimidazoles; Cyclic Nucleotide Phosphodiesterases, Type 5; Daunorubicin; Doxorubicin; fms-Like Tyrosine Kinase 3; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Molecular Targeted Therapy; Morpholines; Nicotinamide Phosphoribosyltransferase; Nitric Oxide; Pyrimidines; Quinazolines; Structure-Activity Relationship; Transcription Factors

2021

Other Studies

1 other study(ies) available for erlotinib and 4,5,6,7-tetrabromo-2-azabenzimidazole

Article	Year
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51 Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases	2007

Article

Year

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.

Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007